Its abnormal expression is associated with cancer development [36], and elevated levels of IGF2BP2 in pancreatic cancer [35, 37], colorectal cancer [38], or esophageal squamous cell carcinoma [34] have been linked to poor prognostic outcomes. The gene discussed is IGF2BP2; the disease is cancer.